Table of Contents Executive Summary 1 Industry Overview of Chronic Myelogenous Leukemia Treatment 1.1 Definition of Chronic Myelogenous Leukemia Treatment 1.2 Chronic Myelogenous Leukemia Treatment Segment By Treatment Type 1.2.1 Global Chronic Myelogenous Leukemia Treatment Production Growth Rate Comparison By Treatment Type (2014-2025) 1.2.2 Disease Specific Treatment 1.2.3 Symptomatic Treatment 1.3 Chronic Myelogenous Leukemia Treatment Segment by Applications 1.3.1 Global Chronic Myelogenous Leukemia Treatment Consumption Comparison by Applications (2014-2025) 1.3.2 Hospital Pharmacies 1.3.3 Specialty Pharmacies 1.3.4 Retail Pharmacies 1.4 Global Chronic Myelogenous Leukemia Treatment Overall Market 1.4.1 Global Chronic Myelogenous Leukemia Treatment Revenue (2014-2025) 1.4.2 Global Chronic Myelogenous Leukemia Treatment Production (2014-2025) 1.4.3 North America Chronic Myelogenous Leukemia Treatment Status and Prospect (2014-2025) 1.4.4 Europe Chronic Myelogenous Leukemia Treatment Status and Prospect (2014-2025) 1.4.5 China Chronic Myelogenous Leukemia Treatment Status and Prospect (2014-2025) 1.4.6 Japan Chronic Myelogenous Leukemia Treatment Status and Prospect (2014-2025) 1.4.7 Southeast Asia Chronic Myelogenous Leukemia Treatment Status and Prospect (2014-2025) 1.4.8 India Chronic Myelogenous Leukemia Treatment Status and Prospect (2014-2025) 2 Manufacturing Cost Structure Analysis 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Chronic Myelogenous Leukemia Treatment 2.3 Manufacturing Process Analysis of Chronic Myelogenous Leukemia Treatment 2.4 Industry Chain Structure of Chronic Myelogenous Leukemia Treatment 3 Development and Manufacturing Plants Analysis of Chronic Myelogenous Leukemia Treatment 3.1 Capacity and Commercial Production Date 3.2 Global Chronic Myelogenous Leukemia Treatment Manufacturing Plants Distribution 3.3 Major Manufacturers Technology Source and Market Position of Chronic Myelogenous Leukemia Treatment 3.4 Recent Development and Expansion Plans 4 Key Figures of Major Manufacturers 4.1 Chronic Myelogenous Leukemia Treatment Production and Capacity Analysis 4.2 Chronic Myelogenous Leukemia Treatment Revenue Analysis 4.3 Chronic Myelogenous Leukemia Treatment Price Analysis 4.4 Market Concentration Degree 5 Chronic Myelogenous Leukemia Treatment Regional Market Analysis 5.1 Chronic Myelogenous Leukemia Treatment Production by Regions 5.1.1 Global Chronic Myelogenous Leukemia Treatment Production by Regions 5.1.2 Global Chronic Myelogenous Leukemia Treatment Revenue by Regions 5.2 Chronic Myelogenous Leukemia Treatment Consumption by Regions 5.3 North America Chronic Myelogenous Leukemia Treatment Market Analysis 5.3.1 North America Chronic Myelogenous Leukemia Treatment Production 5.3.2 North America Chronic Myelogenous Leukemia Treatment Revenue 5.3.3 Key Manufacturers in North America 5.3.4 North America Chronic Myelogenous Leukemia Treatment Import and Export 5.4 Europe Chronic Myelogenous Leukemia Treatment Market Analysis 5.4.1 Europe Chronic Myelogenous Leukemia Treatment Production 5.4.2 Europe Chronic Myelogenous Leukemia Treatment Revenue 5.4.3 Key Manufacturers in Europe 5.4.4 Europe Chronic Myelogenous Leukemia Treatment Import and Export 5.5 China Chronic Myelogenous Leukemia Treatment Market Analysis 5.5.1 China Chronic Myelogenous Leukemia Treatment Production 5.5.2 China Chronic Myelogenous Leukemia Treatment Revenue 5.5.3 Key Manufacturers in China 5.5.4 China Chronic Myelogenous Leukemia Treatment Import and Export 5.6 Japan Chronic Myelogenous Leukemia Treatment Market Analysis 5.6.1 Japan Chronic Myelogenous Leukemia Treatment Production 5.6.2 Japan Chronic Myelogenous Leukemia Treatment Revenue 5.6.3 Key Manufacturers in Japan 5.6.4 Japan Chronic Myelogenous Leukemia Treatment Import and Export 5.7 Southeast Asia Chronic Myelogenous Leukemia Treatment Market Analysis 5.7.1 Southeast Asia Chronic Myelogenous Leukemia Treatment Production 5.7.2 Southeast Asia Chronic Myelogenous Leukemia Treatment Revenue 5.7.3 Key Manufacturers in Southeast Asia 5.7.4 Southeast Asia Chronic Myelogenous Leukemia Treatment Import and Export 5.8 India Chronic Myelogenous Leukemia Treatment Market Analysis 5.8.1 India Chronic Myelogenous Leukemia Treatment Production 5.8.2 India Chronic Myelogenous Leukemia Treatment Revenue 5.8.3 Key Manufacturers in India 5.8.4 India Chronic Myelogenous Leukemia Treatment Import and Export 6 Chronic Myelogenous Leukemia Treatment Segment Market Analysis (by Type) 6.1 Global Chronic Myelogenous Leukemia Treatment Production by Type 6.2 Global Chronic Myelogenous Leukemia Treatment Revenue by Type 6.3 Chronic Myelogenous Leukemia Treatment Price by Type 7 Chronic Myelogenous Leukemia Treatment Segment Market Analysis (by Application) 7.1 Global Chronic Myelogenous Leukemia Treatment Consumption by Application 7.2 Global Chronic Myelogenous Leukemia Treatment Consumption Market Share by Application (2014-2019) 8 Chronic Myelogenous Leukemia Treatment Major Manufacturers Analysis 8.1 Bristol Myers Squibb 8.1.1 Bristol Myers Squibb Chronic Myelogenous Leukemia Treatment Production Sites and Area Served 8.1.2 Bristol Myers Squibb Product Introduction, Application and Specification 8.1.3 Bristol Myers Squibb Chronic Myelogenous Leukemia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.1.4 Main Business and Markets Served 8.2 Novartis 8.2.1 Novartis Chronic Myelogenous Leukemia Treatment Production Sites and Area Served 8.2.2 Novartis Product Introduction, Application and Specification 8.2.3 Novartis Chronic Myelogenous Leukemia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.2.4 Main Business and Markets Served 8.3 Pfizer 8.3.1 Pfizer Chronic Myelogenous Leukemia Treatment Production Sites and Area Served 8.3.2 Pfizer Product Introduction, Application and Specification 8.3.3 Pfizer Chronic Myelogenous Leukemia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.3.4 Main Business and Markets Served 8.4 Teva Pharmaceutical 8.4.1 Teva Pharmaceutical Chronic Myelogenous Leukemia Treatment Production Sites and Area Served 8.4.2 Teva Pharmaceutical Product Introduction, Application and Specification 8.4.3 Teva Pharmaceutical Chronic Myelogenous Leukemia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.4.4 Main Business and Markets Served 8.5 Hoffman-LaRoche 8.5.1 Hoffman-LaRoche Chronic Myelogenous Leukemia Treatment Production Sites and Area Served 8.5.2 Hoffman-LaRoche Product Introduction, Application and Specification 8.5.3 Hoffman-LaRoche Chronic Myelogenous Leukemia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.5.4 Main Business and Markets Served 8.6 Schering Plough 8.6.1 Schering Plough Chronic Myelogenous Leukemia Treatment Production Sites and Area Served 8.6.2 Schering Plough Product Introduction, Application and Specification 8.6.3 Schering Plough Chronic Myelogenous Leukemia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.6.4 Main Business and Markets Served 9 Development Trend of Analysis of Chronic Myelogenous Leukemia Treatment Market 9.1 Global Chronic Myelogenous Leukemia Treatment Market Trend Analysis 9.1.1 Global Chronic Myelogenous Leukemia Treatment Market Size (Volume and Value) Forecast 2019-2025 9.2 Chronic Myelogenous Leukemia Treatment Regional Market Trend 9.2.1 North America Chronic Myelogenous Leukemia Treatment Forecast 2019-2025 9.2.2 Europe Chronic Myelogenous Leukemia Treatment Forecast 2019-2025 9.2.3 China Chronic Myelogenous Leukemia Treatment Forecast 2019-2025 9.2.4 Japan Chronic Myelogenous Leukemia Treatment Forecast 2019-2025 9.2.5 Southeast Asia Chronic Myelogenous Leukemia Treatment Forecast 2019-2025 9.2.6 India Chronic Myelogenous Leukemia Treatment Forecast 2019-2025 9.3 Chronic Myelogenous Leukemia Treatment Market Trend (Product Type) 9.4 Chronic Myelogenous Leukemia Treatment Market Trend (Application) 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.3 Chronic Myelogenous Leukemia Treatment Customers 11 Market Dynamics 11.1 Market Trends 11.2 Opportunities 11.3 Market Drivers 11.4 Challenges 11.5 Influence Factors 12 Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List 13.4 Disclaimer

List of Tables and Figures Figure Picture of Chronic Myelogenous Leukemia Treatment Table Global Chronic Myelogenous Leukemia Treatment Production (K Units) Growth Rate Comparison by Types (2014-2025) Figure Global Chronic Myelogenous Leukemia Treatment Production Market Share by Types in 2018 Figure Disease Specific Treatment Product Picture Figure Symptomatic Treatment Product Picture Table Global Chronic Myelogenous Leukemia Treatment Consumption (K Units) Comparison by Applications (2014-2025) Figure Global Chronic Myelogenous Leukemia Treatment Consumption Market Share by Applications in 2018 Figure Hospital Pharmacies Figure Specialty Pharmacies Figure Retail Pharmacies Figure Global Chronic Myelogenous Leukemia Treatment Revenue (Million USD) (2014-2025) Figure Global Chronic Myelogenous Leukemia Treatment Production (K Units) (2014-2025) Figure North America Chronic Myelogenous Leukemia Treatment Market Size (Million USD) (2014-2025) Figure Europe Chronic Myelogenous Leukemia Treatment Market Size (Million USD) (2014-2025) Figure China Chronic Myelogenous Leukemia Treatment Market Size (Million USD) (2014-2025) Figure Japan Chronic Myelogenous Leukemia Treatment Market Size (Million USD) (2014-2025) Figure Southeast Asia Chronic Myelogenous Leukemia Treatment Market Size (Million USD) (2014-2025) Figure India Chronic Myelogenous Leukemia Treatment Market Size (Million USD) (2014-2025) Table Chronic Myelogenous Leukemia Treatment Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of Chronic Myelogenous Leukemia Treatment in 2018 Figure Manufacturing Process Analysis of Chronic Myelogenous Leukemia Treatment Figure Industry Chain Structure of Chronic Myelogenous Leukemia Treatment Table Capacity and Commercial Production Date of Key Manufacturers Table Global Chronic Myelogenous Leukemia Treatment Manufacturing Plants Distribution Table Chronic Myelogenous Leukemia Treatment Major Manufacturers Technology Source and Market Position Table Recent Development and Expansion Plans in Future Table Chronic Myelogenous Leukemia Treatment Capacity (K Units) of Major Manufacturers (2014-2019) Table Chronic Myelogenous Leukemia Treatment Production (K Units) of Major Manufacturers (2014-2019) Table Chronic Myelogenous Leukemia Treatment Production Market Share of Major Manufacturers (2014-2019) Figure Chronic Myelogenous Leukemia Treatment Production Share by Manufacturers in 2018 Table Chronic Myelogenous Leukemia Treatment Revenue (Million US$) of Major Manufacturers (2014-2019) Table Chronic Myelogenous Leukemia Treatment Revenue Market Share of Major Manufacturers (2014-2019) Figure Chronic Myelogenous Leukemia Treatment Revenue Share by Manufacturers in 2018 Table Chronic Myelogenous Leukemia Treatment Average Price (USD/Unit) of Major Manufacturers (2014-2019) Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Global Chronic Myelogenous Leukemia Treatment Production by Regions 2014-2019 (K Units) Table Global Chronic Myelogenous Leukemia Treatment Production Market Share by Regions 2014-2019 Figure Global Chronic Myelogenous Leukemia Treatment Production Market Share by Regions in 2018 Table Global Chronic Myelogenous Leukemia Treatment Revenue by Regions 2014-2019 (Million USD) Table Global Chronic Myelogenous Leukemia Treatment Revenue Market Share by Regions 2014-2019 Figure Global Chronic Myelogenous Leukemia Treatment Revenue Market Share by Regions in 2018 Table Global Chronic Myelogenous Leukemia Treatment Consumption by Regions 2014-2019 (K Units) Table Global Chronic Myelogenous Leukemia Treatment Consumption Market Share by Regions 2014-2019 Figure North America Chronic Myelogenous Leukemia Treatment Production Growth Rate 2014-2019 (K Units) Figure North America Chronic Myelogenous Leukemia Treatment Revenue Growth Rate 2014-2019 (Million USD) Table North America Chronic Myelogenous Leukemia Treatment Production, Consumption Import and Export (K Units) Figure Europe Chronic Myelogenous Leukemia Treatment Production Growth Rate 2014-2019 (K Units) Figure Europe Chronic Myelogenous Leukemia Treatment Revenue Growth Rate 2014-2019 (Million USD) Table Europe Chronic Myelogenous Leukemia Treatment Production, Consumption Import and Export (K Units) Figure China Chronic Myelogenous Leukemia Treatment Production Growth Rate 2014-2019 (K Units) Figure China Chronic Myelogenous Leukemia Treatment Revenue Growth Rate 2014-2019 (Million USD) Table China Chronic Myelogenous Leukemia Treatment Production, Consumption Import and Export (K Units) Figure Japan Chronic Myelogenous Leukemia Treatment Production Growth Rate 2014-2019 (K Units) Figure Japan Chronic Myelogenous Leukemia Treatment Revenue Growth Rate 2014-2019 (Million USD) Table Japan Chronic Myelogenous Leukemia Treatment Production, Consumption Import and Export (K Units) Figure Southeast Asia Chronic Myelogenous Leukemia Treatment Production Growth Rate 2014-2019 (K Units) Figure Southeast Asia Chronic Myelogenous Leukemia Treatment Revenue Growth Rate 2014-2019 (Million USD) Table Southeast Asia Chronic Myelogenous Leukemia Treatment Production, Consumption Import and Export (K Units) Figure India Chronic Myelogenous Leukemia Treatment Production Growth Rate 2014-2019 (K Units) Figure India Chronic Myelogenous Leukemia Treatment Revenue Growth Rate 2014-2019 (Million USD) Table India Chronic Myelogenous Leukemia Treatment Production, Consumption Import and Export (K Units) Figure Global Consumption Chronic Myelogenous Leukemia Treatment Market Share by Application (2014-2019) Figure Global Value (Consumption) Chronic Myelogenous Leukemia Treatment Market Share by Application (2014-2019) Table Bristol Myers Squibb Chronic Myelogenous Leukemia Treatment Production Sites and Area Served Table Bristol Myers Squibb Chronic Myelogenous Leukemia Treatment Product Introduction, Application and Specification Table Bristol Myers Squibb Chronic Myelogenous Leukemia Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Bristol Myers Squibb Chronic Myelogenous Leukemia Treatment Production Growth Rate (2014-2019) Table Bristol Myers Squibb Chronic Myelogenous Leukemia Treatment Production Market Share (2014-2019) Figure Bristol Myers Squibb Chronic Myelogenous Leukemia Treatment Revenue Market Share (2014-2019) Table Bristol Myers Squibb Chronic Myelogenous Leukemia Treatment Main Business and Markets Served Table Novartis Chronic Myelogenous Leukemia Treatment Production Sites and Area Served Table Novartis Chronic Myelogenous Leukemia Treatment Product Introduction, Application and Specification Table Novartis Chronic Myelogenous Leukemia Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Novartis Chronic Myelogenous Leukemia Treatment Production Growth Rate (2014-2019) Table Novartis Chronic Myelogenous Leukemia Treatment Production Market Share (2014-2019) Figure Novartis Chronic Myelogenous Leukemia Treatment Revenue Market Share (2014-2019) Table Novartis Chronic Myelogenous Leukemia Treatment Main Business and Markets Served Table Pfizer Chronic Myelogenous Leukemia Treatment Production Sites and Area Served Table Pfizer Chronic Myelogenous Leukemia Treatment Product Introduction, Application and Specification Table Pfizer Chronic Myelogenous Leukemia Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Pfizer Chronic Myelogenous Leukemia Treatment Production Growth Rate (2014-2019) Table Pfizer Chronic Myelogenous Leukemia Treatment Production Market Share (2014-2019) Figure Pfizer Chronic Myelogenous Leukemia Treatment Revenue Market Share (2014-2019) Table Pfizer Chronic Myelogenous Leukemia Treatment Main Business and Markets Served Table Teva Pharmaceutical Chronic Myelogenous Leukemia Treatment Production Sites and Area Served Table Teva Pharmaceutical Chronic Myelogenous Leukemia Treatment Product Introduction, Application and Specification Table Teva Pharmaceutical Chronic Myelogenous Leukemia Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Teva Pharmaceutical Chronic Myelogenous Leukemia Treatment Production Growth Rate (2014-2019) Table Teva Pharmaceutical Chronic Myelogenous Leukemia Treatment Production Market Share (2014-2019) Figure Teva Pharmaceutical Chronic Myelogenous Leukemia Treatment Revenue Market Share (2014-2019) Table Teva Pharmaceutical Chronic Myelogenous Leukemia Treatment Main Business and Markets Served Table Hoffman-LaRoche Chronic Myelogenous Leukemia Treatment Production Sites and Area Served Table Hoffman-LaRoche Chronic Myelogenous Leukemia Treatment Product Introduction, Application and Specification Table Hoffman-LaRoche Chronic Myelogenous Leukemia Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Hoffman-LaRoche Chronic Myelogenous Leukemia Treatment Production Growth Rate (2014-2019) Table Hoffman-LaRoche Chronic Myelogenous Leukemia Treatment Production Market Share (2014-2019) Figure Hoffman-LaRoche Chronic Myelogenous Leukemia Treatment Revenue Market Share (2014-2019) Table Hoffman-LaRoche Chronic Myelogenous Leukemia Treatment Main Business and Markets Served Table Schering Plough Chronic Myelogenous Leukemia Treatment Production Sites and Area Served Table Schering Plough Chronic Myelogenous Leukemia Treatment Product Introduction, Application and Specification Table Schering Plough Chronic Myelogenous Leukemia Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Schering Plough Chronic Myelogenous Leukemia Treatment Production Growth Rate (2014-2019) Table Schering Plough Chronic Myelogenous Leukemia Treatment Production Market Share (2014-2019) Figure Schering Plough Chronic Myelogenous Leukemia Treatment Revenue Market Share (2014-2019) Table Schering Plough Chronic Myelogenous Leukemia Treatment Main Business and Markets Served Figure Global Chronic Myelogenous Leukemia Treatment Production (K Units) Growth Rate Forecast 2019-2025 Figure Global Chronic Myelogenous Leukemia Treatment Revenue (Million USD) Growth Rate Forecast 2019-2025 Figure Global Chronic Myelogenous Leukemia Treatment Sales Price (USD/Unit) Forecast 2019-2025 Figure North America Chronic Myelogenous Leukemia Treatment Production Growth Rate Forecast 2019-2025 (K Units) Figure North America Chronic Myelogenous Leukemia Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Europe Chronic Myelogenous Leukemia Treatment Production Growth Rate Forecast 2019-2025 (K Units) Figure Europe Chronic Myelogenous Leukemia Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure China Chronic Myelogenous Leukemia Treatment Production Growth Rate Forecast 2019-2025 (K Units) Figure China Chronic Myelogenous Leukemia Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Japan Chronic Myelogenous Leukemia Treatment Production Growth Rate Forecast 2019-2025 (K Units) Figure Japan Chronic Myelogenous Leukemia Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Southeast Asia Chronic Myelogenous Leukemia Treatment Production Growth Rate Forecast 2019-2025 (K Units) Figure Southeast Asia Chronic Myelogenous Leukemia Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure India Chronic Myelogenous Leukemia Treatment Production Growth Rate Forecast 2019-2025 (K Units) Figure India Chronic Myelogenous Leukemia Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD) Table Global Production (K Units) of Chronic Myelogenous Leukemia Treatment by Type (2019-2025) Table Global Consumption (K Units) of Chronic Myelogenous Leukemia Treatment by Application (2019-2025) Table Chronic Myelogenous Leukemia Treatment Distributors List Table Chronic Myelogenous Leukemia Treatment Customers List Table Market Key Trends Table Key Opportunities Table Market Key Drivers Table Key Challenges Table Key Influence Factors Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Bristol Myers Squibb Novartis Pfizer Teva Pharmaceutical Hoffman-LaRoche Schering Plough